Scientific Online Resource System

Scripta Scientifica Medica

Dupuytren`s disease - new opportunities

Bilyana Bozhanina, Ruslan Popstefanov, Dimitar Raykov

Abstract

Dupuytren contracture is benign fibromatosis of the palmar and digital fascia of the hand. The presentation of the disease is progressive flexion contraction of the digits and impaired function of the hand. The disease is common primarily in north Europe and it is found in Bulgaria as well. Dupuytren`s disease is known in the literature since1614, but there are still unsolved problems. Etiology and pathogenesis is unknown and there are many hypotheses of related exogenous and endogenous factors. Multiple treatment options, including surgery and medical procedures, have been suggested but there is not yet an effective one.

Material and methods: In this survey we represent review of the new concepts of management and treatment of Dupuytren contracture. The most recent treatments used are extensive percutaneous aponeurotomy and lipografting, injecting Clostridium histolyticum collagenase, shockwave therapy and radiotherapy.

Results and conclusion: Each of the treatment options has certain advantages and disadvantages and further investigations are required for better outcomes.


Keywords

Dupuytren contracture; dupuytren`s disease; surgical; treatment

Full Text


References

Peter Brenner GMR. Dupuytren`s Disease: A Concept of Surgical Treatment. 2003. p. 105.

Mikkelsen OA. Epidemiology of a Norwegian population. 1990;

Egawa T, Senrui H, Horiki A. Epidemiology of the oriental patient. 1990;239-45.

Wilbrand S, Ekbom A, Gerdin B. The sex ratio and rate of reoperation for Dupuytren`s contracture in men and women. J. Hand Surg. (British A [Internet]. 1999 [cited 2013 Oct 4]; Available from: http://jhs.sagepub.com/content/24/4/456.short

Ross DC. Epidemiology of Dupuytren`s disease. Hand Clin. [Internet]. Division of Plastic Surgery, University of Western Ontario, Hand and Upper Limb Centre, St. Joseph`s Health Centre, London, Canada.; 1999 Feb;15(1):53-62, vi. Available from: http://europepmc.org/abstract/MED/10050242

Mikkelsen O. The prevalence of Dupuytren`s disease in Norway. Acta Chir Scand [Internet]. 1972 [cited 2013 Oct 6]; Available from: http:// dupuytrenfoundation.org/DupPDFs/1972_ Mikkelsen.pdf

Ling R. The genetic factor in Dupuytren`s disease. J Bone Jt. Surg Br [Internet]. 1963 [cited 2013 Oct 4]; Available from: http://www.bjj.boneandjoint.org. uk/content/45-B/4/709.full.pdf

Renard E, Jacques D, Chammas M, Poirier JL, Bonifacj C, Jaffiol C, et al. Increased prevalence of soft tissue hand lesions in type 1 and type 2 diabetes mellitus: various entities and associated significance. Diabete Metab. [Internet]. Service d`Endocrinologie, Hôpital Lapeyronie, Montpellier, France.; 1994;20(6):513-21. Available from: http:// europepmc.org/abstract/MED/7713273

Arafa M, Noble J, Royle S, Trail I, Allen J. Dupuytren`s and epilepsy revisited. J. Hand Surg. [Internet]. 1992 [cited 2013 Oct 4]; Available from: http://www.sciencedirect.com/science/article/ pii/026676819290095J

Burke F, Proud G, Lawson I. An assessment of the effects of exposure to vibration, smoking, alcohol and diabetes on the prevalence of Dupuytren`s disease in 97,537 miners. J. Hand A [Internet]. 2007 [cited 2013 Oct 4]; Available from: http:// www.sciencedirect.com/science/article/pii/ S1753193407003032

Godtfredsen N, Lucht H. A prospective study linked both alcohol and tobacco to Dupuytren`s disease. J. Clin. A [Internet]. 2004 [cited 2013 Oct 4]; Available from: http://www.sciencedirect.com/ science/article/pii/S0895435604000496

Mafi R, Hindocha S, Khan W. Recent Surgical and Medical Advances in the Treatment of Dupuytren`s Disease - A Systematic Review of the Literature. 2012;77-82.

Ardeshir Bayat Duncan Angus McGrouther. Dupuytren`s disease. Surgery. Published by Elsevier Ltd.; 2006. p. 373-5.

Wurster-Hill DH, Brown F, Park JP, Gibson SH. Cytogenetic studies in Dupuytren contracture. Am. J. Hum. Genet. [Internet]. Department of Pathology, Dartmouth Medical School, Hanover, NH 03756, United States; 1988;43(3):285-92. Available from: http://www.scopus.com/inward/ record.url?eid=2-s2.0-0023714003&partnerID=40 &md5=90b27ff0311913a5a4183386cde62145

Luck JV. Dupuytren` s Contracture: A New Concept of the Pathogenesis Correlated with Surgical Management Dupuytren`s. 2009;

Shaw RB, Chong AKS, Zhang A, Hentz VR, Chang J. Dupuytren`s disease: history, diagnosis, and treatment. Plast. Reconstr. Surg. [Internet]. 2007 Sep [cited 2013 Sep 27];120(3):44e-54e. Available from: http://www.ncbi.nlm.nih.gov/ pubmed/17700106

www.centerforreconstructiveurology.org/ peyronies-disease/causes.htm. lederhose disease.

Eaton C, Seegenschmiedt MH, Bayat A, Gabbiani G, Werker P, Wach W. Dupuytren`s Disease and Related Hyperproliferative Disorders. Eaton C, Seegenschmiedt MH, Bayat A, Gabbiani G, Werker P, Wach W, editors. Springer; 2012.

Green. chapter 5 - Dupuytren ` s Contracture. Green`s Oper. Hand Surgery, 6th ed. 2010th ed. 2010.

Kling RE, Mehrara BJ, Pusic AL, Young VL, Hume KM, Crotty C a, et al. Trends in autologous fat grafting to the breast: a national survey of the american society of plastic surgeons. Plast. Reconstr. Surg. [Internet]. 2013 Jul [cited 2013 Oct 1];132(1):35-46. Available from: http://www.ncbi. nlm.nih.gov/pubmed/23806907

Rehman S, Salway F, Stanley JK, Ollier WER, Day P, Bayat A. Molecular phenotypic descriptors of Dupuytren`s disease defined using informatics analysis of the transcriptome. J. Hand Surg. Am. [Internet]. 2008 Mar [cited 2013 Oct 4];33(3):359- 72. Available from: http://www.ncbi.nlm.nih.gov/ pubmed/18343292

Rijssen ALVAN, Werker PMN. PERCUTANEOUS NEEDLE FASCIOTOMY IN DUPUYTREN`S DISEASE. J. Hand Surg. (British Eur. Vol. 2006;5(31B):498- 501.

Bletan R, Marcireau D, Alnat J. Treatment of Dupuytren`s disease by percutaneous needle fasciotomy. 1832.

Beaudreuil J, Lermusiaux J-L, Teyssedou J-P, Lahalle S, Lasbleiz S, Bernabé B, et al. Multi-needle aponeurotomy for advanced Dupuytren`s disease: preliminary results of safety and efficacy (MNA 1 study). Joint. Bone. Spine [Internet]. Elsevier Masson SAS; 2011 Dec [cited 2013 Oct 1];78(6):625- 8. Available from: http://www.ncbi.nlm.nih.gov/ pubmed/21353618

Thomas A, Bayat A. The emerging role of Clostridium histolyticum collagenase in the treatment of Dupuytren disease. Ther. Clin. Risk Manag. [Internet]. 2010 Jan [cited 2013 Oct 2];6:557-72. Available from: http://www. pubmedcentral.nih.gov/articlerender.fcgi?artid=298 8615&tool=pmcentrez&rendertype=abstract

Gilpin D, Coleman S, Hall S, Houston A, Karrasch J, Jones N. Injectable collagenase Clostridium histolyticum: a new nonsurgical treatment for Dupuytren`s disease. J. Hand Surg. Am. [Internet]. 2010 Dec [cited 2013 Sep 25];35(12):2027-38.e1. Available from: http://www.ncbi.nlm.nih.gov/ pubmed/21134613

Misra A, Jain A, Ghazanfar R, Johnston T, Nanchahal J. Predicting the Outcome of Surgery for the Dupuytren`s Disease. 2002;240-5.

Denkler K. Fasciectomy for Dupuytren ` s Disease: A 20-Year Review of the English Literature. Open Access J. Plast. Surg. 2010;116-33.

Hueston J. Limited fasciectomy for Dupuytren`s contracture. Plast. Reconstr. Surg. 1961

Armstrong J. Dermofasciectomy in the management of Dupuytren`s disease. J. Bone Jt. A [Internet]. 2000 [cited 2013 Oct 4]; Available from: http://www.bjj.boneandjoint.org.uk/content/82- B/1/90.abstract

Beaudreuil J, Lellouche H, Orcel P, Bardin T. Needle aponeurotomy in Dupuytren`s disease. Jt. bone spine Rev. du Rhum. [Internet]. 2012 Jan [cited 2013 Oct 1];79(1):13-6. Available from: http:// www.ncbi.nlm.nih.gov/pubmed/21549632

Rijssen A van, Linden H ter, Werker P. Five-year results of a randomized clinical trial on treatment in Dupuytren`s disease: percutaneous needle fasciotomy versus limited fasciectomy. Plast. Reconstr. Surg. [Internet]. 2012 [cited 2013 Oct 4]; Available from: http://scholar.google.bg/scholar? hl=bg&q=A+comparison+of+the+direct+outcom es+of+per-+cutaneous+needle+fasciotomy+and +limited+fasciectomy+for+Dupuytren`s+disease: +A+6-week+follow-up+study&btnG=#2

Hovius SER, Kan HJ, Smit X, Selles RW, Cardoso E, Khouri RK. Extensive percutaneous aponeurotomy and lipografting: a new treatment for Dupuytren disease. Plast. Reconstr. Surg. [Internet]. 2011 Jul [cited 2013 Sep 30];128(1):221-8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21701337

Degreef I. Therapy-resisting Dupuytren`s disease New perspectives in adjuvant treatment.

Ketchum LD, Donahue TK. The injection of nodules of Dupuytren`s disease with triamcinolone acetonide. J. Hand Surg. Am. [Internet]. 2000;25(6):1157-62. Available from: http:// www.scopus.com/inward/record.url?eid=2-s2.0- 0033750268&partnerID=40&md5=bb8d1badb1226 63fca63a89efe53beaf

Al-Qattan MM, Ketchum LD. The injection of nodules of dupuytren`s disease with triamcinalone acetonide [2]. J. Hand Surg. Am. [Internet]. 2001;26(3):560-1. Available from: http://www. scopus.com/inward/record.url?eid=2-s2.0- 0034986725&partnerID=40&md5=4a47aa861d3fa c64b319f23140f7b0c7

Jerosch-Herold C, Shepstone L, Chojnowski AJ, Larson D. Splinting after contracture release for Dupuytren`s contracture (SCoRD): protocol of a pragmatic, multi-centre, randomized controlled trial. BMC Musculoskelet. Disord. [Internet]. 2008 Jan [cited 2013 Sep 30];9:62. Available from: http:// www.pubmedcentral.nih.gov/articlerender.fcgi?arti d=2386788&tool=pmcentrez&rendertype=abstract

Jerosch-Herold C, Shepstone L, Chojnowski AJ, Larson D, Barrett E, Vaughan SP. Night-time splinting after fasciectomy or dermo-fasciectomy for Dupuytren`s contracture: a pragmatic, multicentre, randomised controlled trial. BMC Musculoskelet. Disord. [Internet]. BioMed Central Ltd; 2011 Jan [cited 2013 Oct 1];12(1):136. Available from: http://www.pubmedcentral.nih.gov/ articlerender.fcgi?artid=3146906&tool=pmcentrez &rendertype=abstract

Hueston J. Enzymic fasciotomy. Hand [Internet]. 1971 Mar [cited 2013 Oct 4];3(1):38- 40. Available from: http://jhs.sagepub.com/cgi/ doi/10.1016/0072-968X(71)90010-6

Watt AJ, Curtin CM, Hentz VR. Collagenase injection as nonsurgical treatment of Dupuytren`s disease: 8-year follow-up. J. Hand Surg. Am. [Internet]. Elsevier Inc.; 2010 Apr [cited 2013 Oct 2];35(4):534-9, 539.e1. Available from: http://www. ncbi.nlm.nih.gov/pubmed/20353858

Starkweather KD, Lattuga S, Hurst LC, Badalamente MA, Brook S, Guilak F, et al. Collagenase in the Treatment of Dupuytren ` s Disease: an In Vitro Study. 1983;490-5.

Rayan GM, Parizi M, Tomasek JJ. Pharmacologic regulation of Dupuytren`s fibroblast contraction in vitro. J. Hand Surg. Am. [Internet]. 1996;21(6):1065-70. Available from: http://www. ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve& db=PubMed&dopt=Citation&list_uids=8969433

Knobloch K, Kuehn M, Vogt PM. Focused extracorporeal shockwave therapy in Dupuytren`s disease--a hypothesis. Med. Hypotheses [Internet]. Elsevier Ltd; 2011 May [cited 2013 Oct 4];76(5):635- 7. Available from: http://www.ncbi.nlm.nih.gov/ pubmed/21277691

Betz N, Ott OJ, Adamietz B, Sauer R, Fietkau R KL. Radiotherapy in early-stage Dupuytren`s contracture. Long-term results after 13 years. Betz. 2010;186(2):82-90.




DOI: http://dx.doi.org/10.14748/ssm.v45i0.938

Refbacks

Article Tools
Email this article (Login required)
About The Authors

Bilyana Bozhanina
St Anna University Hospital of Varna
Bulgaria

Department of Orthopedics and Traumatology

Ruslan Popstefanov
St Anna University Hospital of Varna
Bulgaria

Department of Orthopedics and Traumatology

Dimitar Raykov
St Anna University Hospital of Varna
Bulgaria

Department of Orthopedics and Traumatology

Font Size


|